News Digital health firm Pear considers future as cash dwindles Company looks at possible sale, merger or licensing deal after making big layoffs last year.
Digital DTx and the case for fit-for-purpose evidentiary standard DTx deliver evidence-based therapeutic interventions driven by high-quality software programs
Digital The connected care horizon in 2023 Some connected care trends expected include digital therapeutics & remote patient monitoring.
News Bill seeks Medicare category for digital therapeutics Bipartisan bill would create a payment system for FDA-approved, prescription DTx products.
Digital Newel Health begins next phase of development of Soturi Soturi, Newel Health’s digital therapeutics solution for Parkinson’s Disease (PD), has begun the next phase of development, aiming to v
News South Korea approves its first digital therapeutic An app to treat insomnia has become the first DTx approved for marketing in South Korea.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
